Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures
A primary investment of Rs 194.4 crore has been made
Subscribe To Our Newsletter & Stay Updated
